Smart QA Academy  All lessons

AI in medical devices · Expert · 13 min lesson

Post-market monitoring of AI: performance drift, data collection and triggers

MDR Articles 83 to 88 and Annex III, EU AI Act Article 72, ISO 14971 clause 10, FDA PCCP guidance

What you will learn

Key takeaways

Free practice question

Halden monitors Halden Rhythm only through the complaints inbox. In a year it receives four complaints, all about login problems. A new customer reports privately that the software seems quieter than before, but nobody records the remark.

What is the correct assessment of this surveillance system?

Adequate, because no performance complaint exists.

Not quite. An absence of complaints is not evidence of performance, and MDR Article 83 requires a proactive and systematic system instead.

Inadequate, because it cannot detect silent drift and has no proactive data collection.

Correct. MDR Article 83 and AI Act Article 72(1) require proactive monitoring proportionate to the AI risks, which a complaints inbox cannot give.

Adequate if the inbox is checked daily.

Not quite. Frequency of checking does not make a reactive channel proactive, so Article 83 of the MDR is still not met.

Inadequate only because login complaints were not fixed.

Not quite. Login problems are a separate matter; the defect against Annex III of the MDR is the missing performance monitoring.

Key terms

Official sources

Go further

The full lesson has narrated slides, more scenario questions with explained answers and a simulation.

Open the AcademyWatch on YouTube

Illustrative example. Educational only, not legal advice.